Nothing Special   »   [go: up one dir, main page]

ATE296805T1 - Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität - Google Patents

Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität

Info

Publication number
ATE296805T1
ATE296805T1 AT98931355T AT98931355T ATE296805T1 AT E296805 T1 ATE296805 T1 AT E296805T1 AT 98931355 T AT98931355 T AT 98931355T AT 98931355 T AT98931355 T AT 98931355T AT E296805 T1 ATE296805 T1 AT E296805T1
Authority
AT
Austria
Prior art keywords
specificity
inhibitors
factor
neutral group
neutral
Prior art date
Application number
AT98931355T
Other languages
English (en)
Inventor
Robert Anthony Galemmo Jr
Celia Dominguez
John Matthew Fevig
Qi Han
Patrick Yuk-Sun Lam
Donald Joseph Philip Pinto
James Russell Pruitt
Mimi Lifen Quan
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26758382&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE296805(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Application granted granted Critical
Publication of ATE296805T1 publication Critical patent/ATE296805T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT98931355T 1997-06-19 1998-06-18 Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität ATE296805T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87888597A 1997-06-19 1997-06-19
US7669198P 1998-02-27 1998-02-27
PCT/US1998/012681 WO1998057937A2 (en) 1997-06-19 1998-06-18 Inhibitors of factor xa with a neutral p1 specificity group

Publications (1)

Publication Number Publication Date
ATE296805T1 true ATE296805T1 (de) 2005-06-15

Family

ID=26758382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98931355T ATE296805T1 (de) 1997-06-19 1998-06-18 Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität

Country Status (22)

Country Link
EP (1) EP0991625B1 (de)
JP (1) JP2002507968A (de)
KR (1) KR20010013977A (de)
AR (1) AR015906A1 (de)
AT (1) ATE296805T1 (de)
AU (1) AU8150398A (de)
BR (1) BR9810151A (de)
CA (1) CA2290982A1 (de)
DE (1) DE69830403T2 (de)
EA (1) EA200000048A1 (de)
EE (1) EE9900584A (de)
ES (1) ES2239806T3 (de)
HR (1) HRP980334A2 (de)
HU (1) HUP0003906A2 (de)
IL (1) IL133526A0 (de)
LV (1) LV12516B (de)
NO (1) NO996316L (de)
PL (1) PL337831A1 (de)
PT (1) PT991625E (de)
SI (1) SI20208A (de)
SK (1) SK174699A3 (de)
WO (1) WO1998057937A2 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012150A4 (de) * 1997-05-19 2002-05-29 Sugen Inc Heteroarylcarboxamid-verbindungen die gegen durch protein-tyrosin-kinase verursachte krankheiten wirksam sind
US6271237B1 (en) 1997-12-22 2001-08-07 Dupont Pharmaceuticals Company Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
AU1724499A (en) * 1997-12-22 1999-07-12 Du Pont Pharmaceuticals Company Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
WO1999041231A1 (fr) 1998-02-17 1999-08-19 Ono Pharmaceutical Co., Ltd. Derives amidino utilises comme ingredients actifs et medicaments les contenant
DE69920888T2 (de) 1998-03-27 2006-02-02 Bristol-Myers Squibb Pharma Co. Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren
WO2000006550A1 (fr) * 1998-07-31 2000-02-10 Nippon Soda Co., Ltd. Composes phenylazole, procede de production desdits composes et medicaments pour le traitement de l'hyperlipidemie
AU3127900A (en) * 1998-12-23 2000-07-31 Du Pont Pharmaceuticals Company Thrombin or factor xa inhibitors
JP2002538151A (ja) 1999-03-02 2002-11-12 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド カテプシンの可逆的インヒビターとして有用な化合物
ES2197092T3 (es) 1999-04-02 2004-01-01 Bristol-Myers Squibb Pharma Company Sulfonil arilos como inhibidores del factor xa.
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
TR200102969T2 (tr) 1999-04-15 2002-08-21 Bristol-Myers Squibb Company Siklik protein tirozin kinaz önleyicileri.
BR0013200A (pt) 1999-07-16 2002-05-07 Bristol Myers Squibb Pharma Co Compostos derivados de heterobiciclos contendo nitrogênio, composições farmacêuticas, método de tratamento ou prevenção de uma disfunção tromboembólica e uso dos compostos
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6407256B1 (en) 1999-11-03 2002-06-18 Bristol Myers Squibb Co Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors
WO2001032628A1 (en) * 1999-11-03 2001-05-10 Bristol-Myers Squibb Pharma Company Cyano compounds as factor xa inhibitors
MY138097A (en) 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
WO2002000655A1 (en) * 2000-06-23 2002-01-03 Bristol-Myers Squibb Pharma Company 1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor xa inhibitors
US6599926B2 (en) 2000-06-23 2003-07-29 Bristol-Myers Squibb Company Heteroaryl-phenyl substituted factor Xa inhibitors
AU2001275857A1 (en) * 2000-06-29 2002-01-14 Bristol-Myers Squibb Pharma Company Thrombin or factor xa inhibitors
JP2004514669A (ja) 2000-11-07 2004-05-20 ブリストル−マイヤーズ スクイブ カンパニー セリンプロテアーゼ阻害剤として有用な酸誘導体
US6906192B2 (en) 2000-11-07 2005-06-14 Bristol Myers Squibb Company Processes for the preparation of acid derivatives useful as serine protease inhibitors
EP1332129A2 (de) 2000-11-07 2003-08-06 Bristol-Myers Squibb Company Säurederivate und ihre verwendung als inhibitoren von serinproteasen
MY142967A (en) 2001-08-13 2011-01-31 Du Pont Method for controlling particular insect pests by applying anthranilamide compounds
AR036872A1 (es) 2001-08-13 2004-10-13 Du Pont Compuesto de antranilamida, composicion que lo comprende y metodo para controlar una plaga de invertebrados
WO2003016304A1 (en) 2001-08-15 2003-02-27 E. I. Du Pont De Nemours And Company Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
KR100866463B1 (ko) 2001-08-15 2008-10-31 이 아이 듀폰 디 네모아 앤드 캄파니 무척추 해충 방제용 오르토-치환 아릴 아미드
AU2002326748B8 (en) 2001-08-16 2008-07-10 E.I. Du Pont De Nemours And Company Substituted anthranilamides for controlling invertebrate pests
HU228195B1 (hu) 2001-09-21 2013-01-28 Bristol Myers Squibb Co Pirazolo-piridin gyûrût tartalmazó laktámok és származékaik, valamint az ezeket tartalmazó Xa faktor gátlására szolgáló gyógyszerkészítmények
TW200724033A (en) 2001-09-21 2007-07-01 Du Pont Anthranilamide arthropodicide treatment
TWI320039B (en) 2001-09-21 2010-02-01 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
BR0307178A (pt) 2002-01-22 2004-12-07 Du Pont Composto, composição e método para controle de pragas invertebradas
WO2003099276A1 (en) 2002-05-10 2003-12-04 Bristol-Myers Squibb Company 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
BR0311707A (pt) 2002-06-13 2005-03-15 Du Pont Composto, composição e método de controle de pelo menos uma praga invertebrada
DE10229070A1 (de) * 2002-06-28 2004-01-15 Merck Patent Gmbh Phenylderivate 5
MXPA05005025A (es) 2002-11-15 2005-08-03 Du Pont Nuevos insecticidas de antranilamida.
EP2982668A3 (de) 2002-12-03 2016-04-13 Pharmacyclics LLC 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidin-derivate als faktor viia inhibitoren zur behandlung von thromboembolischen erkrankungen
EP2283898A1 (de) 2002-12-23 2011-02-16 4Sc Ag Cycloalkyl-Verbindungen als ANTI-INFLAMMATORISCHEN, IMMUNOMODULATORISCHEN und antiproliferativen Mittel
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
WO2004056746A1 (en) 2002-12-23 2004-07-08 4Sc Ag Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7247736B2 (en) 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
ZA200505310B (en) 2003-01-28 2006-09-27 Du Pont Cyano anthranilamide insecticides
US7122557B2 (en) * 2003-03-18 2006-10-17 Bristol-Myers Squibb Company Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
US20040220170A1 (en) * 2003-05-01 2004-11-04 Atkinson Robert N. Pyrazole-amides and sulfonamides as sodium channel modulators
CA2525325A1 (en) * 2003-05-01 2004-11-18 Abbott Laboratories Pyrazole-amides and sulfonamides as sodium channel modulators
EP1651612B9 (de) 2003-07-22 2012-09-05 Astex Therapeutics Limited 3,4-disubstituierte 1h-pyrazol-verbindungen und deren verwendung als cyclin-abhängige kinase (cdk) und glycogen synthase kinase-3 (gsk-3) modulatoren
DE602004030689D1 (de) * 2003-07-23 2011-02-03 Synta Pharmaceuticals Corp Verbindungen gegen entzündungen und immun-relevante verwendungen
EP1700856B1 (de) 2003-12-26 2015-11-11 Kyowa Hakko Kirin Co., Ltd. Thiazolderivat
EA011764B1 (ru) 2004-03-05 2009-06-30 Ниссан Кемикал Индастриз, Лтд. Изоксазолинзамещённое производное бензамида и пестицид
AU2005223483B2 (en) 2004-03-18 2009-04-23 Zoetis Llc N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
GT200500179BA (es) 2004-07-01 2008-10-29 Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados
AU2005281934A1 (en) * 2004-09-06 2006-03-16 F. Hoffmann-La Roche Ag 4-aminomethyl benzamidine derivatives and their use as factor VIIA inhibitors
WO2006083477A2 (en) 2005-01-07 2006-08-10 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
US20100280023A1 (en) 2005-06-23 2010-11-04 Kyowa Hakko Kogyo Co., Ltd. Thiazole derivatives
MX2008000502A (es) * 2005-07-15 2008-03-07 Hoffmann La Roche Nuevas aminas ciclicas fusionadas con heteroarilo.
BRPI0617046A2 (pt) 2005-08-24 2011-07-12 Du Pont composto, composição de controle de pragas invertebradas, composição de isca para controle de pragas invertebradas, composição de pulverização para controlar pragas invertebradas, métodos de controle de pragas invertebradas, método de controle de baratas, formigas ou cupins e método de controle de mosquitos, moscas pretas, moscas dos estábulos, moscas do cervos, moscas dos cavalos, vespas, vespas americanas, vespões, carrapatos, aranhas, formigas ou mosquitos
TWI324908B (en) 2006-01-05 2010-05-21 Du Pont Liquid formulations of carboxamide arthropodicides
EP1979334B1 (de) * 2006-01-31 2011-06-22 Dong Wha Pharmaceutical Co., Ltd. Neue benzamidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält
JP5322935B2 (ja) * 2006-07-31 2013-10-23 アクティベサイト ファーマシューティカルズ インコーポレイティッド 血漿カリクレインの阻害薬
EP1894928A1 (de) 2006-08-29 2008-03-05 PheneX Pharmaceuticals AG Fxr bindende heterocyclische verbindungen
WO2008059335A1 (en) 2006-11-13 2008-05-22 Pfizer Products Inc. Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
JP2012509274A (ja) * 2008-11-19 2012-04-19 シェーリング コーポレイション ジアシルグリセロールアシルトランスフェラーゼの阻害薬
BR112012014683B1 (pt) 2009-12-15 2017-11-07 Bayer Cropscience Ag Process for the production of 5-pyrazolcarboxylic acid derivatives 1-alkyl- / 1-aryl-substituted and compound acid
WO2011075684A1 (en) 2009-12-18 2011-06-23 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
NZ610331A (en) * 2010-10-20 2015-01-30 Biota Scient Management Viral polymerase inhibitors
WO2012081916A2 (ko) * 2010-12-17 2012-06-21 한국화학연구원 인다졸 유도체 및 이를 함유하는 살충제 조성물
CN103596936B (zh) 2011-03-31 2016-11-09 拜耳知识产权股份有限公司 具有除草和杀真菌活性的3‑苯基异噁唑啉‑5‑甲酰胺和3‑苯基异噁唑啉‑5‑硫代酰胺
WO2012142308A1 (en) 2011-04-13 2012-10-18 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
ES2583853T3 (es) 2011-10-03 2016-09-22 Respivert Limited 1-Pirazolil-3-(4-((2-anilinopirimidin-4-il)oxi)naftalen-1-il)ureas como inhibidores de p38 MAP cinasa
EP2578582A1 (de) 2011-10-03 2013-04-10 Respivert Limited 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) Harnstoffe als p38 MAP Kinasehemmer
AU2013322855B2 (en) * 2012-09-25 2017-06-22 Bayer Cropscience Ag Herbicidal and fungicidal 5-oxy-substituted 3-phenylisoxazoline-5-carboxamides and 5-oxy-substituted 3-phenylisoxazoline-5-thioamides
BR112015007578B1 (pt) 2012-10-02 2020-05-05 Bayer Cropscience Ag Uso não terapêutico de compostos, compostos, composições emétodo não terapêutico para controlar pragas compreendendoos referidos compostos
TW201444798A (zh) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 作爲強效rock1及rock2抑制劑之苯基吡唑衍生物
JP6423372B2 (ja) 2013-02-28 2018-11-14 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 強力なrock1およびrock2阻害剤としてのフェニルピラゾール誘導体
MX2016011468A (es) 2014-03-07 2017-01-23 Biocryst Pharm Inc Inhibidores de calicreína plasmática humana.
CN104086500B (zh) * 2014-07-23 2015-08-26 张远强 一种par-1拮抗剂及其用途
CN104086492B (zh) * 2014-07-23 2015-12-30 张远强 抗血栓化合物、其制备方法和用途
CN104072436B (zh) * 2014-07-23 2015-10-14 张远强 对位取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104072435B (zh) * 2014-07-23 2015-11-04 张远强 双烷基取代的四氮唑苯乙酮化合物和用途
CN104072431B (zh) * 2014-07-23 2015-11-18 张远强 烷氧基取代的苯基三唑希夫碱结构的化合物及用途
CN104086501B (zh) * 2014-07-23 2016-02-17 张远强 一种par-1拮抗剂、其制备方法和用途
CN104086497B (zh) * 2014-07-23 2016-03-02 张远强 三唑希夫碱类化合物、其制备方法和用途
CN104072437B (zh) * 2014-07-23 2015-10-14 张远强 双取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104086502B (zh) * 2014-07-23 2015-10-14 张远强 卤代四氮唑苯乙酮化合物、其制备方法和用途
CN104086493B (zh) * 2014-07-23 2016-05-18 张远强 末端取代的苯基三唑希夫碱结构的化合物及其用途
CN104072439B (zh) * 2014-07-23 2015-11-04 张远强 卤素取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104072434B (zh) * 2014-07-23 2015-12-02 张远强 间位取代的四氮唑苯乙酮化合物、其制备方法和用途
CN104072432B (zh) * 2014-07-23 2015-12-30 张远强 含苯基取代三唑希夫碱类结构的化合物、其制备方法和用途
CN104086498B (zh) * 2014-07-23 2015-11-18 张远强 末端取代的三唑希夫碱类结构的化合物、其制备方法和用途
CN104086503B (zh) * 2014-07-23 2015-10-14 张远强 Par-1拮抗剂及其用途
CN104072438B (zh) * 2014-07-23 2015-10-14 张远强 二烷氧代四氮唑苯乙酮化合物、其制备方法和用途
MY190027A (en) 2014-08-29 2022-03-22 Torrent Pharmaceuticals Ltd P38 map kinase inhibiting indanyl urea compounds
CN104529928A (zh) * 2015-01-13 2015-04-22 佛山市赛维斯医药科技有限公司 一类恶二唑亚砜化合物、其制备方法和用途
US11613522B2 (en) * 2017-06-13 2023-03-28 Bayer Aktiengesellschaft Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro- and dihydrofurancarboxamides
UA126240C2 (uk) 2017-06-13 2022-09-07 Баєр Акціенгезельшафт Гербіцидно активний 3-фенілізоксазолін-5-карбоксамід тетрагідро- та дигідрофуранкарбонових кислот та складних ефірів
BR112020003266A2 (pt) 2017-08-17 2020-10-13 Bayer Aktiengesellschaft 3-fenil-5-trifluorometilisoxazolina-5-carboxamidas herbicidamente ativas de ésteres e ácidos ciclopentilcarboxílicos
PL3743411T3 (pl) 2018-01-25 2023-03-13 Bayer Aktiengesellschaft Herbicydowo czynne 3-fenyloizoksazolino-5-karboksyamidy z pochodnych kwasów cyklopentenylokarboksylowych
WO2020182723A1 (de) 2019-03-12 2020-09-17 Bayer Aktiengesellschaft Herbizid wirksame 3-phenylisoxazolin-5-carboxamide von s-haltigen cyclopentenylcarbonsäureestern
AU2020417293A1 (en) 2020-01-03 2022-09-01 Berg Llc Polycyclic amides as UBE2K modulators for treating cancer
US20240425491A1 (en) * 2021-05-05 2024-12-26 University College Cardiff Consultants Limited Heteroaryl compounds useful in the treatment of cognitive disorders

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134987A (en) * 1976-01-14 1979-01-16 Huppatz John L Compounds and compositions
ES8103064A1 (es) * 1979-02-22 1981-02-16 Monsanto Co Un procedimiento para preparar acido 2-(3-aril-5-isoxazolil)-benzoico
US4226877A (en) * 1979-05-14 1980-10-07 Abbott Laboratories Pyrazoles active in the central nervous system
DE3065190D1 (en) 1979-11-05 1983-11-10 Beecham Group Plc Enzyme derivatives, and their preparation
DE3420985A1 (de) * 1983-10-15 1985-04-25 Bayer Ag, 5090 Leverkusen Substituierte 5-acylamino-1-phenylpyrazole
IL73419A (en) * 1983-11-07 1988-02-29 Lilly Co Eli 1h-pyrazole-4-(thio)carboxamide derivatives,their preparation and herbicidal compositions containing them
DE3540839A1 (de) * 1985-11-18 1987-05-27 Bayer Ag 1-aryl-pyrazole
DE3633840A1 (de) * 1986-10-04 1988-04-14 Hoechst Ag Phenylpyrazolcarbonsaeurederivate, ihre herstellung und verwendung als pflanzenwachstumsregulatoren und safener
DE3706993A1 (de) * 1987-03-05 1988-09-15 Bayer Ag 5-amino-3-halogenalkyl-1-aryl-pyrazole
JPS6425763A (en) * 1987-04-24 1989-01-27 Mitsubishi Chem Ind Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
DE3808896A1 (de) * 1988-03-17 1989-09-28 Hoechst Ag Pflanzenschuetzende mittel auf basis von pyrazolcarbonsaeurederivaten
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
DE4013723A1 (de) * 1990-04-28 1991-10-31 Basf Ag 5-(1,2,4-triazol-1-ylmethyl)-isoxazoline
GB9017694D0 (en) 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH07509452A (ja) * 1992-07-24 1995-10-19 メルク シヤープ エンド ドーム リミテツド イミダゾール,トリアゾール及びテトラゾール誘導体
US5262412A (en) * 1993-03-10 1993-11-16 Merck & Co., Inc. Substituted pyrazoles, compositions and use
JPH09505589A (ja) 1993-11-24 1997-06-03 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー フィブリノーゲン受容体アンタゴニストとして有用なイソオキサゾリン化合物
ES2154326T3 (es) * 1993-11-24 2001-04-01 Du Pont Pharm Co Antagonistas de receptor de fibrinogeno de isoxazolina e isoxazol.
US5446056A (en) 1993-11-24 1995-08-29 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5563158A (en) * 1993-12-28 1996-10-08 The Dupont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
DE4405207A1 (de) * 1994-02-18 1995-08-24 Bayer Ag N-Pyrazolylaniline und N-Pyrazolylaminopyridine
ES2208737T3 (es) * 1995-03-10 2004-06-16 Berlex Laboratories, Inc. Derivados de benzamidina, su preparacion y su utilizacion como anticoagulantes.
IL118007A0 (en) 1995-05-24 1996-08-04 Du Pont Merck Pharma Isoxazoline compounds pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
CA2290982A1 (en) 1998-12-23
DE69830403D1 (de) 2005-07-07
BR9810151A (pt) 2000-08-08
NO996316D0 (no) 1999-12-17
LV12516B (en) 2001-03-20
ES2239806T3 (es) 2005-10-01
KR20010013977A (ko) 2001-02-26
EP0991625A2 (de) 2000-04-12
EA200000048A1 (ru) 2000-08-28
DE69830403T2 (de) 2006-02-02
PL337831A1 (en) 2000-09-11
EP0991625B1 (de) 2005-06-01
JP2002507968A (ja) 2002-03-12
WO1998057937A2 (en) 1998-12-23
AR015906A1 (es) 2001-05-30
WO1998057937A3 (en) 1999-03-18
HUP0003906A2 (hu) 2001-05-28
LV12516A (en) 2000-07-20
SI20208A (sl) 2000-10-31
EE9900584A (et) 2000-08-15
PT991625E (pt) 2005-10-31
SK174699A3 (en) 2000-08-14
IL133526A0 (en) 2001-04-30
AU8150398A (en) 1999-01-04
HRP980334A2 (en) 1999-04-30
NO996316L (no) 1999-12-17

Similar Documents

Publication Publication Date Title
DE69830403D1 (de) Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität
DE69801014D1 (de) Wellrohr
NO20003808D0 (no) Substituerte oksoazaheterosyklylfaktor Xa inhibitorer
DE69817148D1 (de) Schallschutzwand mit entkoppler
DK0884060T3 (da) Manchetforsynet rør
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
DE69738851D1 (de) Inorganisches phosphordüngemittel
DE69816168D1 (de) Rohrverbindung
DE69812770D1 (de) Rohrverbindung
NO20001644L (no) Forbedret komposittborerør
DE69821941D1 (de) Lokalisierung von eingegrabenen leitungen
NO20003256D0 (no) ACE inhibitor-MMP inhibitor kombinasjoner
BR9612707A (pt) Composiç o detergente compreendendo uma enzima pectinesterase
NO20002852D0 (no) Rørforbindelse
ID19641A (id) Alat untuk menyediakan tenaga putaran
DE69812512D1 (de) Einfach einführbarer Reiniger für Rohre
DE59808755D1 (de) Rohrverbindung
ID19110A (id) Setater alat pengubah pijar
LT99146A (en) Inhibitors of factor xa with a neutral p1 specificity group
NO20002937D0 (no) Fibrinogen-konverterende enzymhybrider
FI944396A0 (fi) Kiraalinen polarisaatiomuunnin
DE69808480D1 (de) Dudelsackpfeifen
KR950027711U (ko) 암면 분사기
NO970605L (no) Kombinert r°rverkt°y
BR7700393U (pt) Construtividade aplicada a tijolo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties